Preoperative autologous donation of 6 units of blood during rh-EPO treatment

Canadian Journal of Anaesthesia

Volumn 44, Issue 12, 1997, Pages 1315-1318

  Milbrink, Jan ^a   Birgegård, Gunnar ^a   Danersund, Antero ^a   Helmers, Claes ^b   Nordström, Lars ^b   Sandhagen, Bo ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b Boehringer Mannheim Scandinavia   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD DONOR; BLOOD GROUP RHESUS SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HIP ARTHROPLASTY; HUMAN; IRON THERAPY; MALE; PHLEBOTOMY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REOPERATION; RETICULOCYTE;

EID: 2642696819     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03012783     Document Type: Article

References (14)

1. Goodnough LT, Shafron D, Marcus RE. The impact of preoperative autologous blood donation in orthopaedic surgical practice. Vox Sang 1990; 59: 65-9.
2. Birgegård G, Danersund A, Högman C, Milbrink J, Wide L. Physiological response to phlebotomies for autologous transfusion at elective hip-joint surgery. Eur J Haematol 1991; 46: 136-9.
3. Goodnough LT, Price TH, Friedman KD, et al. A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy. Transfusion 1994; 34: 66-71.
4. Güse HG, Wens K, Behr W, et al. Preoperative autologous blood donation with rhEPO therapy in patients scheduled for cardiac surgery: preliminary results of a dose-response finding multicenter trial. In: Bauer CKK, Scigalla P, Wieczorek L (Eds.). Erythropoietin: Molecular Physiology and Clinical Applications. New York: Dekker Inc, 1993: 411-24.
5. Kyo S, Omoto R, Hirashima K, Eguchi S, Fajita T. Effect of human recombinant erythropoietin on reduction of homologous blood transfusion in open-heart surgery. Circulation 1992; 86: II-413-8.
6. Mercuriali F, Zanella A, Barosi G, et al. Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients. Transfusion 1993; 33: 55-60.
7. Murphy P, Heal JM, Blumberg N. Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusions. Transfusion 1991; 31: 212-7.
8. Owings DV, Kruskall MS, Thurer RL, Donovan LM. Autologous blood donations prior to elective cardiac surgery. Safety and effect on subsequent blood use. JAMA 1989; 262: 1963-8.
9. Osswald PM, Osmers A, Lorentz A, et al. Dose-response relationship of rhEPO in preoperative autologous blood donation in patients scheduled for elective orthopedic surgery. In: Bauer CKK, Scigalla P, Wieczorek L (Eds.). Erythropoietin: Molecular Physiology and Clinical Applications. New York: Dekker Inc, 1993: 425-41.
10. Pineda AA, Brzica SM Jr, Taswell HF. Hemolytic transfusion reaction. Recent experience in a large blood bank. Mayo Clin Proc 1978; 53: 378-90.
11. Popovsky MA, Abel MD, Moors SB. Transfusion-related acute lung injury associated with passive transfer of antileucocyte antibodies. Am Rev Respir Dis 1983; 128: 185-9.
12. Siggaard-Andersen O, Wimberly PD, Fogh-Andersen N, Gøthgen IH. Measured and derived quantities with modern pH and blood gas equipment: calculation algorithms with 54 equations. Scand J Clin Lab Invest 1988; 48(Suppl 189): 7-15.
13. Walker RH. Special report: transfusion risks. Am J CIin Pathol 1987; 88: 374-8.
14. Bommer J, Barth H-P, Zeier M, et al. Efficacy comparison of intravenous and subcutanous recombinant human erythropoietin administration in hemodialysis patients. In: Gurland HJ, Moran J, Samtleben W, Scigalla P, Wieczorek L (Eds.). Erythropoietin in Renal and Non-Renal Anemias. Contrib Nephrol. Basel: Karger 1991; 88: 136-43.